These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 8852599

  • 21. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
    Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Jolliffe LK, Colvin RB.
    Surgery; 1990 Aug; 108(2):406-13; discussion 413-4. PubMed ID: 2382234
    [Abstract] [Full Text] [Related]

  • 22. Failure of anti-T cell monoclonal antibodies to prevent acute tumor allograft rejection is associated with their inability to deplete or inactivate T cells at the site of rejection.
    Rakhmilevich AL.
    Transplantation; 1994 Jul 15; 58(1):72-80. PubMed ID: 7913562
    [Abstract] [Full Text] [Related]

  • 23. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.
    Transplantation; 1997 May 15; 63(9):1243-51. PubMed ID: 9158016
    [Abstract] [Full Text] [Related]

  • 24. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys.
    Mourad GJ, Preffer FI, Wee SL, Powelson JA, Kawai T, Delmonico FL, Knowles RW, Cosimi AB, Colvin RB.
    Transplantation; 1998 Mar 15; 65(5):632-41. PubMed ID: 9521196
    [Abstract] [Full Text] [Related]

  • 25. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study.
    Transplantation; 1997 Apr 27; 63(8):1087-95. PubMed ID: 9133469
    [Abstract] [Full Text] [Related]

  • 26. Lymphocyte function in patients treated with monoclonal anti-T3 antibody for acute cadaveric renal allograft rejection.
    Bowen A, Edwards LC, Gailiunas P, Helderman JH.
    Transplantation; 1984 Nov 27; 38(5):489-93. PubMed ID: 6388070
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo.
    Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G, Forni G.
    Science; 1985 Jul 12; 229(4709):176-9. PubMed ID: 3160110
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pretreatment of renal transplants with anti-CD45 antibodies: optimization of perfusion technique.
    Goldberg LC, Cook T, Taube D.
    Transpl Immunol; 1994 Jul 12; 2(1):27-34. PubMed ID: 8081787
    [Abstract] [Full Text] [Related]

  • 34. Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR.
    Blank G, Welker C, Haarer J, Sterk M, Nadalin S, Yañez VA, Joos TO, Menrad A, Snell D, LaCorcia G, Königsrainer A, Handgretinger R, Schilbach K.
    Bone Marrow Transplant; 2015 Mar 12; 50(3):390-401. PubMed ID: 25402416
    [Abstract] [Full Text] [Related]

  • 35. Rational design of biologically active peptides: inhibition of T cell activation through interference with CD4 function. Transplant Int (2000) 13 [Suppl 1]: S306-S310.
    Pozzetto U, Facchiano A, Serino F.
    Transpl Int; 2000 Mar 12; 13(6):456-61. PubMed ID: 11140247
    [Abstract] [Full Text] [Related]

  • 36. Anti-CD4 monoclonal antibody administration in renal transplanted patients.
    Morel P, Vincent C, Cordier G, Panaye G, Carosella E, Revillard JP.
    Clin Immunol Immunopathol; 1990 Sep 12; 56(3):311-22. PubMed ID: 2390809
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
    Liang H, Liao C, Qi Z, Sha C, Xie B, Chen J, Xia J, Wang Y, Yao Q, Zhao Y.
    Transpl Immunol; 2010 Feb 12; 22(3-4):128-36. PubMed ID: 19755159
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK, Shelby J, Eichwald EJ.
    Transplantation; 1992 Apr 12; 53(4):849-57. PubMed ID: 1533070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.